人工子宮施設市場- 世界の産業規模、シェア、動向、機会、予測、技術別、用途別、エンドユーザー別、地域別、競争別、2020-2030F予測

人工子宮施設の世界市場は、2024年には3億1,225万米ドルとなり、予測期間には6億2,535万米ドルに達すると予測され、2030年までのCAGRは12.27%です。

世界の人工子宮施設市場は変革の瀬戸際にあります。医療技術の進歩と代替妊娠方法への関心の高まりにより、人工子宮はもはやSFの概念ではなく現実のものとなっています。この画期的なイノベーションは、妊娠と出産に革命をもたらし、家族、ヘルスケアプロバイダー、研究者に多くの機会を提供することを約束します。人工子宮は人工子宮室とも呼ばれ、自然の子宮の状態を再現し、人体外の胎児の成長と開発をサポートする装置です。早産児やリスクのある胎児が生存可能な段階に達するまで発育を続けられるよう、管理された環境を提供することを目的としており、早産に伴う合併症を軽減できる可能性があります。これらの機器は、従来の妊娠に関連する様々な医学的・倫理的課題を軽減する上で有用です。

市場促進要因

母体死亡率の減少が世界の人工子宮施設市場を牽引

主な市場課題

倫理的・道徳的懸念

主要市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の人工子宮施設市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 技術別（バイオリアクター、抽出支援装置、その他）
  • 用途別（産前ケア、新生児ケア）
  • エンドユーザー別（専門病院、研究センター、体外受精センター（IVF））
  • 地域別
  • 企業別（2024）
• 市場マップ
  • 技術別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 アジア太平洋地域の人工子宮施設市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の人工子宮施設市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の人工子宮施設市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の人工子宮施設市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの人工子宮施設市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の人工子宮施設市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• American University of Beirut（AUB）
• Biotex Inc.
• California Preterm Birth Initiative
• Emmaus Life Sciences, Inc.
• Hebrew University
• Institute of Life Sciences
• Juno Perinatal Healthcare
• Sera Prognostics, Inc.
• Shanghai First Maternity and Infant Hospital
• SomaGenics Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Artificial Womb Facility Market was valued at USD 312.25 Million in 2024 and is expected to reach USD 625.35 Million in the forecast period with a CAGR of 12.27% through 2030. The Global Artificial Womb Facility Market is on the brink of transformation. With advancements in medical technology and a growing interest in alternative methods of gestation, the artificial womb is no longer just a concept from science fiction but a reality. This groundbreaking innovation promises to revolutionize pregnancy and childbirth, offering a multitude of opportunities for families, healthcare providers, and researchers. An artificial womb, also known as an ectogenesis chamber, is a device that replicates the conditions of a natural womb to support the growth and development of a fetus outside of a human body. It aims to provide a controlled environment where a preterm or at-risk fetus can continue to develop until it reaches a viable stage, potentially reducing the complications associated with premature births. These devices can be instrumental in alleviating various medical and ethical challenges associated with traditional pregnancies.

Key Market Drivers

Reduction in Maternal Mortality is Driving the Global Artificial Womb Facility Market

Maternal mortality, a tragic and largely preventable occurrence, has long been a global concern. The World Health Organization (WHO) defines maternal mortality as the death of a woman during pregnancy, childbirth, or within 42 days of termination of pregnancy, irrespective of the duration and site of the pregnancy. While significant progress has been made in reducing maternal mortality rates worldwide, it continues to be a critical issue, particularly in developing countries. As we strive for better healthcare outcomes, one innovative solution is emerging as a potential game-changer: the artificial womb facility. This technology has the potential to significantly reduce maternal mortality and drive the global artificial womb facility market. Maternal mortality is a multifaceted problem that reflects not only the health of women but also the accessibility and quality of healthcare services. The root causes of maternal mortality are varied and complex, including inadequate prenatal care, limited access to healthcare facilities, cultural and social factors, and medical complications during pregnancy and childbirth. According to the WHO, approximately 810 women die every day from preventable causes related to pregnancy and childbirth. This equates to over 295,000 maternal deaths annually. Artificial wombs, often referred to as "ectogenesis," are a groundbreaking technological development in the field of reproductive medicine. These devices aim to provide an environment outside the human body where a developing fetus can thrive. While still in the experimental stage, artificial wombs hold the promise of transforming reproductive healthcare by reducing the risks associated with pregnancy and childbirth. One of the most significant advantages of artificial wombs is the potential to eliminate many of the risks that pregnant women face during the gestational period. Maternal mortality often results from complications related to pregnancy, including preeclampsia, hemorrhage, infections, and obstructed labor. With artificial wombs, the fetus can be safely nurtured outside the mother's body, reducing the risk of these life-threatening complications.

Key Market Challenges

Ethical and Moral Concerns

The ethical and moral concerns surrounding artificial wombs are significant and complex. Questions about when life begins, the potential for misuse, and the creation of a dystopian society where human reproduction is entirely divorced from natural processes have raised red flags among many stakeholders. Striking a balance between technological progress and ethical considerations is a daunting task that the market must confront.

Key Market Trends

Technological Advancements

Technological advancements have played a pivotal role in transforming various aspects of our lives. In recent years, these advancements have extended their reach into the field of healthcare and, specifically, artificial womb technology. The development and adoption of artificial womb facilities are on the rise, driven by increasing technological innovations, which have the potential to revolutionize the way we care for premature babies and address various reproductive health challenges. The progress in biotechnology has led to significant breakthroughs in artificial womb technology. Biocompatible materials, improved incubation systems, and better understanding of fetal development have made it possible to create an environment that closely mimics the mother's womb. Artificial placenta systems have been developed to provide the necessary oxygen and nutrients to the developing fetus, effectively bypassing the need for a natural placenta. This breakthrough technology is a game-changer for the care of premature infants. Technological advancements have allowed for the miniaturization of components, making artificial womb facilities more compact and efficient. This portability can potentially enable care for premature infants in various healthcare settings.

Key Market Players

• American University of Beirut (AUB)
• Biotex Inc.
• California Preterm Birth Initiative
• Emmaus Life Sciences, Inc.
• Hebrew University
• Institute of Life Sciences
• Juno Perinatal Healthcare
• Sera Prognostics, Inc.
• Shanghai First Maternity and Infant Hospital
• SomaGenics Inc.

Report Scope:

In this report, the Global Artificial Womb Facility Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Artificial Womb Facility Market, By Technology:

• Bioreactors
• Extrauter in Support Devices
• Others

Artificial Womb Facility Market, By Application:

• Prenatal Care
• Neonatal Care

Artificial Womb Facility Market, By End user:

• Super Specialty Hospitals
• Research Centers
• In-Vitro Fertilization Centers (IVF)

Artificial Womb Facility Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Artificial Womb Facility Market.

Available Customizations:

Global Artificial Womb Facility market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Artificial Womb Facility Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Technology (Bioreactors, Extrauter in Support Devices, Others)
  • 4.2.2. By Application (Prenatal Care, Neonatal Care)
  • 4.2.3. By End user (Super Specialty Hospitals, Research Centers, In-Vitro Fertilization Centers (IVF))
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Technology
  • 4.3.2. By Application
  • 4.3.3. By End user
  • 4.3.4. By Region

5. Asia Pacific Artificial Womb Facility Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology
  • 5.2.2. By Application
  • 5.2.3. By End user
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Artificial Womb Facility Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Technology
      • 5.3.1.2.2. By Application
      • 5.3.1.2.3. By End user
  • 5.3.2. India Artificial Womb Facility Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Technology
      • 5.3.2.2.2. By Application
      • 5.3.2.2.3. By End user
  • 5.3.3. Australia Artificial Womb Facility Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Technology
      • 5.3.3.2.2. By Application
      • 5.3.3.2.3. By End user
  • 5.3.4. Japan Artificial Womb Facility Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Technology
      • 5.3.4.2.2. By Application
      • 5.3.4.2.3. By End user
  • 5.3.5. South Korea Artificial Womb Facility Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Technology
      • 5.3.5.2.2. By Application
      • 5.3.5.2.3. By End user

6. Europe Artificial Womb Facility Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Application
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Artificial Womb Facility Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End user
  • 6.3.2. Germany Artificial Womb Facility Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End user
  • 6.3.3. Spain Artificial Womb Facility Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End user
  • 6.3.4. Italy Artificial Womb Facility Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Technology
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By End user
  • 6.3.5. United Kingdom Artificial Womb Facility Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Technology
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By End user

7. North America Artificial Womb Facility Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Application
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Artificial Womb Facility Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End user
  • 7.3.2. Mexico Artificial Womb Facility Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End user
  • 7.3.3. Canada Artificial Womb Facility Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End user

8. South America Artificial Womb Facility Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Application
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Artificial Womb Facility Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End user
  • 8.3.2. Argentina Artificial Womb Facility Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End user
  • 8.3.3. Colombia Artificial Womb Facility Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End user

9. Middle East and Africa Artificial Womb Facility Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Application
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Artificial Womb Facility Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End user
  • 9.3.2. Saudi Arabia Artificial Womb Facility Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End user
  • 9.3.3. UAE Artificial Womb Facility Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End user

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Artificial Womb Facility Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. American University of Beirut (AUB)
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Product & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Biotex Inc.
• 14.3. California Preterm Birth Initiative
• 14.4. Emmaus Life Sciences, Inc.
• 14.5. Hebrew University
• 14.6. Institute of Life Sciences
• 14.7. Juno Perinatal Healthcare
• 14.8. Sera Prognostics, Inc.
• 14.9. Shanghai First Maternity and Infant Hospital
• 14.10.SomaGenics Inc.

15. Strategic Recommendations

16. About Us & Disclaimer